Navigation Links
Phase 2a Data for MEDI-528 Presented at CHEST 2008
Date:10/29/2008

PLYMOUTH MEETING, Pa., Oct. 29 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today reported that development partner MedImmune, Inc. presented interim Phase 2a data on MEDI-528, its monoclonal antibody (MAb) targeting interleukin-9 (IL-9) in adults with mild, persistent asthma, at The American College of Chest Physicians meeting held October 25-30 in Philadelphia, Pennsylvania.

The presentation, entitled "Multiple Subcutaneous Doses of MEDI-528, A Monoclonal Antibody Against Interleukin-9 in Mild and Moderate Asthmatics," reported the absence of serious, dose-limiting adverse events in the study and concluded that the data demonstrate an acceptable safety profile for multiple subcutaneous doses of MEDI-528.

About IL-9

IL-9 is one of at least 29 naturally occurring interleukins in the human body. Overexpression of IL-9 in animal models has been shown to result in many features of asthma, including increased airway inflammation and hyperreactivity. Blocking the actions of IL-9 has been shown to reduce the airway inflammation and increased airway inflammation and increased airway hyperresponsiveness seen in animal models of asthma. MedImmune is conducting research to evaluate the potential to use MAbs targeting IL-9 to treat or prevent symptomatic, moderate-to-severe, persistent asthma.

About Genaera

Genaera Corporation is developing trodusquemine (MSI-1436) for type 2 diabetes and obesity currently in phase 1 clinical testing and has a fully out-licensed partnership with MedImmune, Inc. that is in phase 2 clinical testing in asthma. For further information, please see our website at http://www.genaera.com.

This announcement contains f
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ovation further advances development pipeline with new phase III epilepsy study
2. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
3. Mannatech Launches Phase One of New Sales and Training Tools
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Manic phase of bipolar disorder benefits from breast cancer medication
6. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 The nation’s first trial ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) is now underway in California Superior ... opening statements were presented on May 28th, with ... the Profemur hip replacement made the device brittle ... just three years after it had been implanted ...
(Date:6/2/2015)... “ Radaris ” was featured on NewsWatch as ... the latest and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... a person. , According to Psychology Today, humans are a ... explain that curiosity is a part of human development. People ...
(Date:6/2/2015)... Milton Hershey School® graduate Vincent Klomps ’10 ... of the Physician Assistant Program’s entering class of 2015 ... with a white coat, which symbolizes his entrance into ... of Vincent’s accomplishments both at MHS and postgraduation,” said ... of how a top-notch education can lead to achievement ...
(Date:6/2/2015)... Erbelli’s Gourmet Pizzeria, Italian Bistro & Pub ... gourmet pizzas and calzones, fresh wraps, submarine sandwiches, and ... the recipes are not—they have been satisfying the taste ... the site is the menu, which is broken up ... the items. You can order directly from the website ...
(Date:6/2/2015)... 02, 2015 IMPAK Corporation, a ... has announced the availability of “child-resistant” pouches and ... by children, especially curious toddlers. The Child Resistant ... tested to CFR 1700.20 protocols. The announcement was ... Looks Like Candy, “With the proliferation of consumer ...
Breaking Medicine News(10 mins):Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 3Health News:A Comprehensive People Search Application Was Featured on NewsWatch Television 2Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2
... , Republican Congressman Slated to ... h and Insurance Campaign Contributions , , ... conflict of interest questions about Rep. Charles Boustany (R-La.) and the ... Barack Obama,s speech to a joint session of Congress on health ...
... , , KEYSTONE TREATMENT AND OUTREACH ... SIMILAR EVENTS TO FOLLOW AT CANTON AT 1 PM: , KEYSTONE ... Media welcome at both locations , , SIOUX FALLS ... Falls, S.D. will be the 2009 national headquarters at 11 AM Wednesday, September ...
... , , , ... LLC, a leading infant formula company, has introduced Bright Beginnings(R) ... Beginnings(R) NeoCare(TM) is a milk-based infant formula intended to meet ... hospital discharge. , , Clinical evidence suggests ...
... produces mild infection, but severe reactions can result , WEDNESDAY, ... has been infected with the West Nile virus, whether they ... since the virus first appeared in North America in 1999, ... journal Emerging Infectious Diseases . , Several West Nile ...
... Industries Ltd. (NYSE: NBR ) invites you to join Eugene M. Isenberg, Chairman and ... third quarter 2009. Nabors will release earnings after the market closes on October 20, 2009. , ... October 21, 2009, Time: ... a.m. ET), Dial-in-number:, Domestic: ...
... , , LEWISTON, Maine and ... presenting sponsor of The Dempsey Challenge: A Journey for Hope, a cycling ... event supports The Patrick Dempsey Center for Cancer Hope & Healing at ... provides an opportunity to expand Amgen,s Breakaway from Cancer ((R)) ...
Cached Medicine News:Health News:Rep. Boustany Hauled in $1.25 Million From Health and Insurance Industry 2Health News:Wed., Sept. 16, 11 AM News Conference: Sioux Falls' Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Celebrating Recovery Against New Wave of Drug Abuse; Former U.S. Drug Czar/4-Star Gen. Barry McCaffrey, Lieute 2Health News:Bright Beginnings(R) NeoCare(TM) Value-Priced Weight Gain Infant Formula Now Available Online at www.pbmstore.com 2Health News:Study Shows 1% of Americans Have Been Infected With West Nile 2Health News:Study Shows 1% of Americans Have Been Infected With West Nile 3Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 2Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 3Health News:Amgen Named Presenting Sponsor of The Dempsey Challenge: A Journey For Hope 4
(Date:6/2/2015)... June 2, 2015  Psychemedics Corporation (NASDAQ: PMD ... twenty-five years, announced the addition of 2 new drugs ... growing abuse concerns, the addition of Oxymorphone was made ... added as an option to the Amphetamine panel. ... stated:  "Sadly, more and more prescription drugs are being ...
(Date:6/2/2015)... , June 02, 2015 Research ... addition of the "Motion Simulation Market by ... DOF, Three DOF, and Six DOF), Application (Automotive, ... and Region - Forecast to 2020 " ... simulation is considered to have matured enough for ...
(Date:6/2/2015)... 2, 2015  Lannett Company, Inc. (NYSE: ... the acquisition of privately held, Silarx Pharmaceuticals, Inc. ... a manufacturer and marketer of liquid generic pharmaceutical ... to acquire Silarx on May 15, 2015.   ... evaluating a number of potential acquisitions, we are ...
Breaking Medicine Technology:Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3Global Motion Simulation Market 2015-2020 - Type, Degree of Freedom, Application, and Regional Analysis 2Lannett Completes Acquisition Of Silarx Pharmaceuticals, Inc. 2
... NEW YORK, Oct. 19 Reportlinker.com announces ... available in its catalogue: ... Pharmaceutical Market in China: Growth strategies, performance ... http://www.reportlinker.com/p0315841/The-Top-10-Companies-in-the-Hospital-Pharmaceutical-Market-in-China-Growth-strategies-performance-and-SWOT-analyses.html China is currently ...
... Reportlinker.com announces that a new market ... Triple Analysis: Apoptosis, Angiogenesis ... http://www.reportlinker.com/p0284949/Triple-Analysis-Apoptosis-Angiogenesis-and-Protein-Kinase-Inhibitors.html This triple ... by mechanism/target/effect of Apoptosis, Angiogenesis and Protein ...
Cached Medicine Technology:Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 2Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 3Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 4Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 5Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 6Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 7Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 8Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses 9Reportlinker Adds Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors 2Reportlinker Adds Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors 3Reportlinker Adds Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors 4Reportlinker Adds Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors 5
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... The Ulti-Mist™ HME product line has ... from pediatrics to adults and from intubated ... offer superior humidification for both anesthesia and ... and HME/Filters provide maximum protection for patients ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
Medicine Products: